Membrane fusion between retroviral particles: Host-range extension and vaccine prospects

Virology

Volumn 271, Issue 2, 2000, Pages 248-252

  Sparacio, Sandra ^a   Zeilfelder, Udo ^a   Pfeiffer, Tanya ^a   Henzler, Tanja ^a   Bosch, Valerie ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

CD4; Cellular receptor; CXCR 4; HIV glycoprotein; Host range; Human immunodeficiency virus; Interviral fusion; Transduction; Vaccine; VSV G

Indexed keywords

CELL RECEPTOR; CHEMOKINE RECEPTOR CXCR4; VIRUS GLYCOPROTEIN; VIRUS VACCINE;

ARTICLE; CONTROLLED STUDY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MARKER GENE; MEMBRANE FUSION; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS INFECTION; VIRUS INHIBITION; VIRUS MORPHOLOGY; VIRUS PARTICLE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES; UNIDENTIFIED RETROVIRUS; VESICULAR STOMATITIS VIRUS;

EID: 0034608246     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0294     Document Type: Article

References (20)

1. LaCasse R. A., Follis K. E., Trahey M., Scarborough J. D., Littman D. R., Nunberg J. H. Fusion-competent vaccines: Broad neutralisation of primary isolates of HIV. Science. 283:1999;357-362.
2. Young J. A. T., Bates P., Willert K., Varmus H. E. Efficient incorporation of human CD4 protein into avian leukosis virus particles. Science. 250:1990;1421-1423.
3. Henriksson P., Bosch V. Inhibition of cellular glycoprotein incorporation into human immunodeficiency virus-like particles by coexpression of additional cellular interaction partner. Virology. 251:1998;16-21.
4. Schnell M. J., Johnson J. E., Buonocore L., Rose J. K. Construction of a novel virus that targets HIV-1 infected cells and controls HIV-1 infection. Cell. 90:1997;849-857.
5. Endres M. J., Jaffer S., Haggarty B., Turner J. D., Doranz B. J., O'Brien P. J., Kolson D. L., Hoxie J. A. Targeting of HIV- and SIV-infected cells by CD4-chemokine receptor pseudotypes. Science. 278:1997;1462-1464.
6. + cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G. J. Virol. 70:1996;2581-2585.
7. Aiken C. Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for nef and the sensitivity to cyclosporin A. J. Virol. 71:1997;5871-5877.
8. cdc2 activity. J. Virol. 69:1995;6705-6711.
9. Krüger U., Pfeiffer T., Bosch V. Generation of lymphocyte cell lines coexpressing CD4 and wild-type or mutant HIV type 1 glycoproteins: Implications for HIV type 1 Env-induced cell lysis. AIDS Res. Hum. Retroviruses. 12:1996;783-790.
10. Schlegel R., Tralka T. S., Willingham C., Pastan I. Inhibition of VSV binding and infectivity by phosphatidylserine: Is phosphatidylserine a VSV-binding site? Cell. 32:1983;639-646.
11. Mastromarino P., Conti C., Goldoni P., Hautttecoeur B., Orsi N. Characterisation of membrane components of the erythrocyte involved in vesicular stomatitis virus attachment and fusion at acidic pH. J. Gen. Virol. 68:1987;2359-2369.
12. Deng H., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., Di Marzio P., Marmon S., Sutton R. E., Hill C. M., Davis C. B., Peiper S. C., Schall T. J., Littman D. R., Landau N. R. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 381:1996;661-666.
13. Adachi A., Gendelman H. E., Koenig S., Folks T., Willey R., Rabson A., Martin M. A. Production of acquired immunodeficiency syndrome-associated retrovirus in human and non-human cells transfected with an infectious molecular clone. J. Virol. 59:1986;284-291.
14. Corbeau P., Kraus G., Wong-Staal F. Efficient gene transfer by a human immunodeficiency virus type 1 (HIV-1)-derived vector utilizing a stable HIV packaging cell line. Proc. Natl. Acad. Sci. USA. 93:1996;14070-14075.
15. Krausslich H. G., Ochsenbauer C., Traenckner A. M., Mergener K., Facke M., Gelderblom H. R., Bosch V. Analysis of protein expression and virus-like particle formation in mammalian cells lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase. Virology. 192:1993;605-617.
16. Freed E. O., Myers D. J., Risser R. Characterisation of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41. Proc. Natl. Acad. Sci. USA. 87:1990;4650-4654.
17. Lasky L. A., Nakamura G., Smith D. H., Fennie C., Shimasaki C., Patzer E., Berman P., Gregory T., Capon D. J. Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell. 50:1987;975-985.
18. Endres M. J., Clapham P. R., Marsh M., Ahuja M., Turner J. D., McKnight A., Thomas J. F., Stoebenau-Haggarty B., Choe S., Vance P. J., Wells T. N., Power C. A., Sutterwala S. S., Doms R. W., Landau N. R., Hoxie J. A. CD4-independant infection by HIV-2 is mediated by fusin/CXCR-4. Cell. 87:1996;745-756.
19. McCallus D. E., Ugen K. E., Sato A. I., Williams W. V., Weiner D. B. Construction of a recombinant bacterial human CD4 expression system producing a bioactive CD4 molecule. Viral Immunol. 5:1992;163-172.
20. Waterfield M. D., Mayes E. L., Stroobant P., Bennet P. L., Young S., Goodfellow P. N., Banting G. S., Ozanne B. A monoclonal antibody to the epidermal growth factor receptor. J. Cell Biochem. 20:1982;149-161.